Table 2.
Biochemical characteristics in control and type 2 diabetes patients
| Control (n = 30) | Type 2 diabetes (n = 40) | P | |
|---|---|---|---|
| FPG (mg/dL) | 85.10 ± 13.37 | 149.25 ± 51.74 | <0.0001 |
| HbA1c (%) | 5.51 ± 0.74 | 7.74 ± 2.04 | <0.0001 |
| TG (mg/dL) | 127.20 ± 28.16 | 190.68 ± 56.45 | 0.001 |
| TC (mg/dL) | 172.30 ± 30.28 | 233.55 ± 38.70 | 0.001 |
| HDL-c (mg/dL) | 41.60 ± 4.00 | 34.8 ± 6.30 | 0.04 |
| LDL-c (mg/dL) | 110.80 ± 26.20 | 142.1 ± 28.20 | 0.001 |
| VLDL-c (mg/dL) | 23.36 ± 3.72 | 47.40 ± 7.34 | <0.0001 |
| TG/HDL-c (mg/dL) | 2.33 ± 0.42 | 6.27 ± 1.25 | <0.0001 |
| TC/HDL-c (mg/dL) | 3.41 ± 0.65 | 6.30 ± 1.82 | <0.0001 |
| FI (UI/mL) | 10.63 ± 6.92 | 18.57 ± 10.24 | <0.0001 |
| HOMA-IR | 2.33 ± 1.65 | 5.29 ± 3.30 | <0.0001 |
Data are shown as mean ± standard deviation. FPG, fasting plasma glucose; FI, fasting insulin; HbA1c, glycated hemoglobin; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment of insulin resistance; LDL, low-density lipoprotein; TC, total cholesterol; TG, triglycerides.